PixelData
PixelData Raises $250M Series E to Transform Biotech
Quick Facts
PixelData Raises $250M Series E in Latest Funding Round
PixelData has successfully closed a $250M Series E funding round, marking a significant milestone in the company's growth trajectory. The round was led by Y Combinator, with participation from Lightspeed Venture Partners.
Company Overview
Founded in 2023 and headquartered in Washington, DC, PixelData has established itself in the Biotech space. Leading AI-powered analytics platform transforming data into actionable business insights
With a current valuation of $15B, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $250M Series E
- Valuation: $15B
- Lead Investor: Y Combinator
Future Outlook
As PixelData moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza